Sayson, Khimberlie .
HRN: 26-18-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2024
METRONIDAZOLE 500MG (TAB)
11/10/2024
11/16/2024
PO
500 Mg Tab
TID
SP LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes